Crispin JC, Liossis SN, Kis-Toth K, Lieberman LA, Kyttaris VC, Juang YT, Tsokos GC: Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med. 2010, 16: 47-57. 10.1016/j.molmed.2009.12.005.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tsokos GC: Systemic lupus erythematosus. N Engl J Med. 2011, 365: 2110-2121. 10.1056/NEJMra1100359.
Article
CAS
PubMed
Google Scholar
Gatenby P, Lucas R, Swaminathan A: Vitamin D deficiency and risk for rheumatic diseases: an update. Curr Opin Rheumatol. 2013, 25: 184-191. 10.1097/BOR.0b013e32835cfc16.
Article
CAS
PubMed
Google Scholar
Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, Shoenfeld Y, Lerchbaum E, Llewellyn DJ, Kienreich K, Soni M: Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013, 12: 976-989. 10.1016/j.autrev.2013.02.004.
Article
CAS
PubMed
Google Scholar
Yang CY, Leung PS, Adamopoulos IE, Gershwin ME: The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol. 2013, 45: 217-226. 10.1007/s12016-013-8361-3.
Article
CAS
PubMed
Google Scholar
Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A: Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006, 296: 2832-2838. 10.1001/jama.296.23.2832.
Article
CAS
PubMed
Google Scholar
Cantorna MT, Hayes CE, DeLuca HF: 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr. 1998, 128: 68-72.
CAS
PubMed
Google Scholar
Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R: Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia. 1994, 37: 552-558. 10.1007/BF00403372.
Article
CAS
PubMed
Google Scholar
Cantorna MT, Munsick C, Bemiss C, Mahon BD: 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr. 2000, 130: 2648-2652.
CAS
PubMed
Google Scholar
Lemire JM, Archer DC: 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest. 1991, 87: 1103-1107. 10.1172/JCI115072.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lemire JM, Ince A, Takashima M: 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity. 1992, 12: 143-148. 10.3109/08916939209150321.
Article
CAS
PubMed
Google Scholar
Abe J, Nakamura K, Takita Y, Nakano T, Irie H, Nishii Y: Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin D3. J Nutr Sci Vitaminol. 1990, 36: 21-31. 10.3177/jnsv.36.21.
Article
CAS
PubMed
Google Scholar
Vaisberg MW, Kaneno R, Franco MF, Mendes NF: Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice. J Clin Lab Anal. 2000, 14: 91-96. 10.1002/(SICI)1098-2825(2000)14:3<91::AID-JCLA2>3.0.CO;2-O.
Article
CAS
PubMed
Google Scholar
Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS: Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev. 2006, 5: 114-117. 10.1016/j.autrev.2005.05.009.
Article
CAS
PubMed
Google Scholar
Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M: Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int. 2009, 20: 427-433. 10.1007/s00198-008-0676-1.
Article
CAS
PubMed
Google Scholar
Hamza RT, Awwad KS, Ali MK, Hamed AI: Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity. Med Sci Monit. 2011, 17: CR711-CR718.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vacca A, Cormier C, Piras M, Mathieu A, Kahan A, Allanore Y: Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol. 2009, 36: 1924-1929. 10.3899/jrheum.081287.
Article
CAS
PubMed
Google Scholar
Holick MF: Vitamin D deficiency. N Engl J Med. 2007, 357: 266-281. 10.1056/NEJMra070553.
Article
CAS
PubMed
Google Scholar
Hewison M, Zehnder D, Bland R, Stewart PM: 1alpha-hydroxylase and the action of vitamin D. J Mol Endocrinol. 2000, 25: 141-148. 10.1677/jme.0.0250141.
Article
CAS
PubMed
Google Scholar
Malaviya AN, Singh RR, Singh YN, Kapoor SK, Kumar A: Prevalence of systemic lupus erythematosus in India. Lupus. 1993, 2: 115-118. 10.1177/096120339300200209.
Article
CAS
PubMed
Google Scholar
Kumar A, Malaviya AN, Singh RR, Singh YN, Adya CM, Kakkar R: Survival in patients with systemic lupus erythematosus in India. Rheumatol Int. 1992, 12: 107-109. 10.1007/BF00290264.
Article
CAS
PubMed
Google Scholar
Murali R, Jeyaseelan L, Rajaratnam S, John L, Ganesh A: Systemic lupus erythematosus in Indian patients: prognosis, survival and life expectancy. Natl Med J India. 1997, 10: 159-164.
CAS
PubMed
Google Scholar
Vijay J, Kapil U: Vitamin d deficiency and its health consequences - a review. Indian J. Community Health. 2012, 24: 232-236.
Google Scholar
Panda AK, Parida JR, Tripathy R, Pattanaik SS, Ravindran B, Das BK: Low producer MBL genotypes are associated with susceptibility to systemic lupus erythematosus in Odisha, India. Hum Immunol. 2013, 74: 114-119.
Article
CAS
PubMed
Google Scholar
Panda AK, Parida JR, Tripathy R, Pattanaik SS, Ravindran B, Das BK: Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity. Arthritis Res Ther. 2012, 14: R218-10.1186/ar4057.
Article
CAS
PubMed
PubMed Central
Google Scholar
Panda AK, Pattanaik SS, Tripathy R, Das BK: TLR-9 promoter polymorphisms (T-1237C and T-1486C) are not associated with systemic lupus erythematosus: A case control study and meta-analysis. Hum Immunol. 2013, 74: 1672-1678. 10.1016/j.humimm.2013.08.006.
Article
CAS
PubMed
Google Scholar
Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40: 1725-
Article
CAS
PubMed
Google Scholar
Danchenko N, Satia JA, Anthony MS: Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006, 15: 308-318. 10.1191/0961203306lu2305xx.
Article
CAS
PubMed
Google Scholar
Palmer P, Tovey MG, Raschilas F, Brassart L, Meritet JF, Porcher R, Lebon P: Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factors. Eur Cytokine Netw. 2007, 18: 108-114.
CAS
PubMed
Google Scholar
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.
Article
CAS
PubMed
Google Scholar
Ronnblom L: Potential role of IFN alpha in adult lupus. Arthritis Res Ther. 2010, 12: S3-10.1186/ar2884.
Article
PubMed
PubMed Central
Google Scholar
Niewold TB, Clark DN, Salloum R, Poole BD: Interferon alpha in systemic lupus erythematosus. J Biomed Biotechnol. 2010, 2010: 948364-
Article
PubMed
PubMed Central
Google Scholar
Bikle DD: Vitamin D and immune function: understanding common pathways. Curr Osteoporos Rep. 2009, 7: 58-63. 10.1007/s11914-009-0011-6.
Article
PubMed
Google Scholar
Cutolo M, Otsa K: Review: vitamin D, immunity and lupus. Lupus. 2008, 17: 6-10. 10.1177/0961203307085879.
Article
CAS
PubMed
Google Scholar
Clemens TL, Adams JS, Henderson SL, Holick MF: Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet. 1982, 1: 74-76.
Article
CAS
PubMed
Google Scholar
Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C: Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford). 2008, 47: 920-923. 10.1093/rheumatology/ken121.
Article
CAS
Google Scholar
Muller K, Kriegbaum NJ, Baslund B, Sorensen OH, Thymann M, Bentzen K: Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol. 1995, 14: 397-400. 10.1007/BF02207671.
Article
CAS
PubMed
Google Scholar
Chen TC, Chimeh F, Lu Z, Mathieu J, Person KS, Zhang A, Kohn N, Martinello S, Berkowitz R, Holick MF: Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys. 2007, 460: 213-217. 10.1016/j.abb.2006.12.017.
Article
CAS
PubMed
PubMed Central
Google Scholar
Toloza SM, Cole DE, Gladman DD, Ibanez D, Urowitz MB: Vitamin D insufficiency in a large female SLE cohort. Lupus. 2010, 19: 13-19. 10.1177/0961203309345775.
Article
CAS
PubMed
Google Scholar
Terrier B, Derian N, Schoindre Y, Chaara W, Geri G, Zahr N, Mariampillai K, Rosenzwajg M, Carpentier W, Musset L, Piette JC, Six A, Klatzmann D, Saadoun D, Patrice C, Costedoat-Chalumeau N: Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther. 2012, 14: R221-10.1186/ar4060.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ritterhouse LL, Crowe SR, Niewold TB, Kamen DL, Macwana SR, Roberts VC, Dedeke AB, Harley JB, Scofield RH, Guthridge JM, James JA: Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis. 2011, 70: 1569-1574.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cantorna MT, Mahon BD: Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004, 229: 1136-1142.
CAS
Google Scholar
Chambers ES, Hawrylowicz CM: The impact of vitamin D on regulatory T cells. Curr Allergy Asthma Rep. 2011, 11: 29-36. 10.1007/s11882-010-0161-8.
Article
CAS
PubMed
Google Scholar
Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK: Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 2005, 52: 1491-1503. 10.1002/art.21031.
Article
CAS
PubMed
Google Scholar
Dall’era MC, Cardarelli PM, Preston BT, Witte A, Davis JC: Type I interferon correlates with serological and clinical manifestations of SLE. Ann Rheum Dis. 2005, 64: 1692-1697.
Article
PubMed
PubMed Central
Google Scholar
Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP: Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum. 2006, 54: 2951-2962. 10.1002/art.22044.
Article
CAS
PubMed
Google Scholar
Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V: Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003, 197: 711-723. 10.1084/jem.20021553.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reichel H, Koeffler HP, Tobler A, Norman AW: 1 alpha,25-dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A. 1987, 84: 3385-3389. 10.1073/pnas.84.10.3385.
Article
CAS
PubMed
PubMed Central
Google Scholar
Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R: Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun. 2000, 270: 701-708. 10.1006/bbrc.2000.2490.
Article
CAS
PubMed
Google Scholar